Equities Analysts Offer Predictions for Acadia Healthcare Company, Inc.’s Q3 2024 Earnings (NASDAQ:ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Research analysts at Zacks Research decreased their Q3 2024 earnings per share (EPS) estimates for shares of Acadia Healthcare in a report issued on Monday, October 14th. Zacks Research analyst Z. Masood now expects that the company will post earnings of $0.88 per share for the quarter, down from their previous estimate of $0.90. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.51 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.83 EPS, FY2024 earnings at $3.46 EPS, Q1 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.98 EPS, Q4 2025 earnings at $1.05 EPS, FY2025 earnings at $3.86 EPS and Q1 2026 earnings at $0.93 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The company had revenue of $796.00 million for the quarter, compared to the consensus estimate of $784.38 million. During the same period last year, the business posted $0.92 earnings per share. The firm’s revenue was up 8.8% compared to the same quarter last year.

A number of other equities research analysts have also commented on ACHC. Barclays decreased their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Royal Bank of Canada restated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft raised their target price on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, KeyCorp initiated coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $56.96 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a market cap of $5.28 billion, a P/E ratio of -406.86, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. Acadia Healthcare has a twelve month low of $53.22 and a twelve month high of $87.77. The firm’s 50-day simple moving average is $71.64 and its 200-day simple moving average is $69.88.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of ACHC. Harbor Capital Advisors Inc. bought a new position in Acadia Healthcare in the second quarter worth approximately $800,000. TCW Group Inc. boosted its stake in Acadia Healthcare by 63.8% in the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock worth $4,247,000 after purchasing an additional 24,487 shares during the period. SG Americas Securities LLC boosted its position in shares of Acadia Healthcare by 435.6% in the second quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock valued at $1,231,000 after acquiring an additional 14,824 shares during the period. Principal Financial Group Inc. lifted its stake in Acadia Healthcare by 19.4% in the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after purchasing an additional 104,359 shares in the last quarter. Finally, Texas Permanent School Fund Corp grew its position in shares of Acadia Healthcare by 11.3% during the 2nd quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock valued at $6,067,000 after purchasing an additional 9,115 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.